Table 2.
Effect of various pharmacological treatments on oxidative stress parameters in rats
Parameter | Group | ||||
---|---|---|---|---|---|
Vehicle control | Cisplatin control (5 mg/kg, i.p.) | Cisplatin + sinapic (20 mg/kg, p.o.) | Cisplatin + sinapic 40 mg | Cisplatin + sinapic 40mg + BADGE | |
TBARS (µM/mg of protein) | 0.45 ± 0.04 | 1.55 ± 0.05a | 0.75 ± 0.04b | 0.58 ± 0.03b | 1.28 ± 0.07c |
SAG (µM/mg of tissue) | 21.4 ± 0.64 | 65.2 ±1.39a | 45.1 ± 1.24b | 35.2 ± 0.86b | 62.8 ± 1.38c |
MPO (U/g of tissue) | 1.79 ± 0.52 | 6.91 ± 0.91a | 5.02 ± 2.31b | 2.06 ± 0.63b | 5.24 ± 0.96c |
GSH (mM/mg of protein) | 16.2 ± 0.41 | 5.35 ± 0.52a | 12.65 ± 0.52b | 14.18 ± 0.33b | 7.82 ± 0.64c |
TBARS = thiobarbituric acid reactive substances, SAG = superoxide anion generation, MPO = myeloperoxidase, GSH = glutathione, BADGE = bisphenol A diglycidyl ether, i.p. = intraperitoneal, p.o. = orally
Data were expressed as mean ± standard error of mean (n = 6)
aP < 0.05 versus vehicle control group
bP < 0.05 versus cisplatin (5 mg/kg, i.p.)
cP < 0.05 versus cisplatin + sinapic acid (40 mg/kg, p.o.)